Viewing Study NCT04400994


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2025-12-27 @ 11:21 PM
Study NCT ID: NCT04400994
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-08
First Post: 2020-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus
Sponsor: The University of Hong Kong
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module